RADIONUCLIDE IMAGING AND THERAPY OF NEUROENDOCRINE TUMOURS
The incidence and prevalence of neuroendocrine tumours (NETs) are on the rise. Although NETs are a heterogeneous group of tumours, they have some similar properties, for example, that they can concentrate neuroamines and tend to have a high degree of somatostatin receptor (SSR) expression. These mec...
Main Authors: | Shaunak Navalkissoor, Gopinath Gnanasegaran |
---|---|
Format: | Article |
Language: | English |
Published: |
Shaukat Khanum Memorial Trust
2015-11-01
|
Series: | Journal of Cancer and Allied Specialties |
Online Access: | http://journals.sfu.ca/jcas/index.php/jcas/article/view/30 |
Similar Items
-
Neuroendocrine Tumours : From Radiomolecular Imaging to Radionuclide Therapy
by: GEORGIOS eLIMOURIS
Published: (2012-02-01) -
Recent advances in radiological and radionuclide imaging and therapy of neuroendocrine tumours.
by: Kaltsas, G, et al.
Published: (2004) -
Targeted radionuclide therapy for neuroendocrine tumours: principles and application.
by: Druce, MR, et al.
Published: (2010) -
Pituitary function following peptide receptor radionuclide therapy for neuroendocrine tumours
by: Marianne S. Elston, et al.
Published: (2021-12-01) -
Radionuclide imaging and therapy in patients with neuroendocrine tumors
by: Olga D. Baranova, et al.
Published: (2018-03-01)